iPSC model helps to better understand genetic lung/liver disease

Using patient-derived stem cells known as induced pluripotent stem cells to study the genetic lung/liver disease called alpha-1 antitrypsin deficiency, researchers have for the first time created a disease signature that may help explain how abnormal protein leads to liver disease. Using patient-derived stem cells known as induced pluripotent stem cells to study the genetic lung/liver disease called alpha-1 antitrypsin deficiency, researchers have for the first time created a disease signature that may help explain how abnormal protein leads to liver disease.

http://ift.tt/1bRKHnn